Globitair

Novo buys rights to Chinese weight-loss pill in $2.6bn deal

Financial TimesPeople's Republic of China

Hengrui Pharma’s experimental drug could be taken just once a week

Read the full story at Financial TimesOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about People's Republic of China